Disease | prostate cancer |
Symptom | C0002871|anaemia |
Sentences | 3 |
PubMedID- 23984103 | Studies have shown that s.c. administration of recombinant human erythropoietin (150 u/kg three times weekly) is an effective treatment for managing poorly tolerated anaemia in men with androgen-independent prostate cancer, achieving a greater than 10% increase in haemoglobin concentrations . |
PubMedID- 19863346 | Erythropoiesis pathology and causes of anaemia in prostate cancer are reviewed. |
PubMedID- 20540802 | anaemia and thrombocytopenia in patients with prostate cancer and bone metastases. |
Page: 1